Literature DB >> 24074865

Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs.

Francesco Neri1, Anna Krepelova, Danny Incarnato, Mara Maldotti, Caterina Parlato, Federico Galvagni, Filomena Matarese, Hendrik G Stunnenberg, Salvatore Oliviero.   

Abstract

The de novo DNA methyltransferase 3-like (Dnmt3L) is a catalytically inactive DNA methyltransferase that cooperates with Dnmt3a and Dnmt3b to methylate DNA. Dnmt3L is highly expressed in mouse embryonic stem cells (ESCs), but its function in these cells is unknown. Through genome-wide analysis of Dnmt3L knockdown in ESCs, we found that Dnmt3L is a positive regulator of methylation at the gene bodies of housekeeping genes and, more surprisingly, is also a negative regulator of methylation at promoters of bivalent genes. Dnmt3L is required for the differentiation of ESCs into primordial germ cells (PGCs) through the activation of the homeotic gene Rhox5. We demonstrate that Dnmt3L interacts with the Polycomb PRC2 complex in competition with the DNA methyltransferases Dnmt3a and Dnmt3b to maintain low methylation levels at the H3K27me3 regions. Thus, in ESCs, Dnmt3L counteracts the activity of de novo DNA methylases to maintain hypomethylation at promoters of bivalent developmental genes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24074865     DOI: 10.1016/j.cell.2013.08.056

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  75 in total

1.  TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.

Authors:  F Neri; D Dettori; D Incarnato; A Krepelova; S Rapelli; M Maldotti; C Parlato; P Paliogiannis; S Oliviero
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

Review 2.  Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease.

Authors:  Isabel Beerman; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2015-06-04       Impact factor: 24.633

3.  Evidence that DNA methylation engenders dynamic gene regulation.

Authors:  Miles F Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

4.  Two miRNA clusters reveal alternative paths in late-stage reprogramming.

Authors:  Ronald J Parchem; Julia Ye; Robert L Judson; Marie F LaRussa; Raga Krishnakumar; Amy Blelloch; Michael C Oldham; Robert Blelloch
Journal:  Cell Stem Cell       Date:  2014-03-13       Impact factor: 24.633

Review 5.  Interpreting the language of histone and DNA modifications.

Authors:  Scott B Rothbart; Brian D Strahl
Journal:  Biochim Biophys Acta       Date:  2014-03-12

Review 6.  Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution.

Authors:  Guillermo Montalbán Bravo; Elinor Lee; Bryan Merchan; Hagop M Kantarjian; Guillermo García-Manero
Journal:  Br J Haematol       Date:  2014-06-05       Impact factor: 6.998

7.  Stable methylation at promoters distinguishes epiblast stem cells from embryonic stem cells and the in vivo epiblasts.

Authors:  Anne-Clémence Veillard; Hendrik Marks; Andreia Sofia Bernardo; Luc Jouneau; Denis Laloë; Laurent Boulanger; Anita Kaan; Vincent Brochard; Matteo Tosolini; Roger Pedersen; Henk Stunnenberg; Alice Jouneau
Journal:  Stem Cells Dev       Date:  2014-06-12       Impact factor: 3.272

8.  PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.

Authors:  Hao Zhang; Ahmed Diab; Huitao Fan; Saravana Kumar Kailasam Mani; Ronald Hullinger; Philippe Merle; Ourania Andrisani
Journal:  Cancer Res       Date:  2015-04-08       Impact factor: 12.701

Review 9.  Hepatitis viruses exploitation of host DNA methyltransferases functions.

Authors:  Valerio Pazienza; Concetta Panebianco; Angelo Andriulli
Journal:  Clin Exp Med       Date:  2015-07-07       Impact factor: 3.984

10.  The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53.

Authors:  Jonathan E Sandoval; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-10-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.